Supplementary Materials from Phase IIA Trial Testing Erlotinib as an Intervention against Intraductal Pancreatic Mucinous Neoplasms
Year: 2023
Type: supplementary-materials
Abstract: Supplementary Materials from Phase IIA Trial Testing Erlotinib as an Intervention against Intraductal Pancreatic Mucinous Neoplasms
Authors: Steven Lipkin, John Lee, David Imagawa, Stephen M. Hewitt, Chris Tucker, Jason A. Zell, Vanessa Wong, Angela Garcia, Rachel Gonzalez, Gary Della Zanna, Ellen Richmond, L.M. Rodriguez, M Bigg, F Schnoll-Sussmans, Frank Meyskens
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4362637381